In the future, pharmacological PIEZO1 blockade or biomechanical modulation may preserve BBB integrity, attenuate leukocyte infiltration, and limit neurovascular inflammation in disorders such as multiple sclerosis, vascular dementia, and CNS malignancies. This evidence concerns the gene PIEZO1 and multiple sclerosis.